🇺🇸 FDA
Patent

US 8592464

Nitric oxide furoxan derivative compounds endowed with antitumoral activity

granted A61PA61P29/00A61P31/00

Quick answer

US patent 8592464 (Nitric oxide furoxan derivative compounds endowed with antitumoral activity) held by HUMANITAS MIRASOLE S.P.A. expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
HUMANITAS MIRASOLE S.P.A.
Grant date
Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P29/00, A61P31/00, A61P35/00, A61P35/04